Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - INNOVUS PHARMACEUTICALS, INC. | innv8k_jan62016.htm |
January 6, 2016
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentleman:
We have read Item 4.01 of the Form 8-K of INNOVUS PHARMACEUTICALS, INC. dated January 6, 2016, and are in agreement with the statements contained in paragraph 1 and 2 therein as it regards our firm. We have no basis to agree or disagree with other statements of the registrant contained in Item 4.01
Sincerely,
/S/ EisnerAmper LLP
EisnerAmper LLP